Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR100HG
   Synonyms MIR100HG, AGD1, linc-NeD125, lncRNA-N2
   Region GRCh38_11:122028327-122556721    Sequence
   Ensembl ENSG00000255248
   RefSeq NR_024430
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name hepatocellular carcinoma
   ICD-0-3 C22.0  M8170/3
   Methods qPCR etc.
   Sample hepatocellular carcinoma tissues, cell lines (MHCC97L, SMCC-7721, Huh-7, MHCC97H and LO2)
   Expression Pattern up-regulated
   Function Description

We totally identified a set of four lncRNAs(MIR100HG, SERHL, CTD-2574D22.4 and SNHG20) that were significantly correlated with patient's survival. We then measured the expression levels of these four lncRNAs using TCGA data, and found that it was significantly up-regulated in HCC tumors compared with normal tissues. Further analysis indicated that three lncRNAs showed a positive coefficient in univariate analysis(SERHL, CTD-2574D22 and SNHG20), suggesting that a higher level of expression was associated with shorter survival. The negative coefficient for the remaining one lncRNAs(MIR100HG)suggested that their higher expression levels were associated with longer survival.

   Pubmed ID 29684484
   Year 2018
   Title Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
   External Links
   Links for  MIR100HG GenBank       HGNC       lncrnadb       Noncode
   Links for  hepatocellular carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.